The Asia-Pacific Direct fed Microbials Market was worth USD 120.11 million in 2021 and estimated to be growing at a CAGR of 7.80%, to reach USD 292.44 million by 2026.
Direct fed microbial-based feed plays a crucial role in providing medicinal and health benefits to livestock, for example, prevention and cure of diseases. Lactic acid bacteria are broadly utilized for feed of poultry and ruminants, for healthy development.
Asia-Pacific Direct Fed Microbials Market Drivers:
The market is driven by factors such as increase in awareness about sustain quality and safety, rising demand for fabricated animal nourish, growth in demand for animal protein, changes in farming practices and technology, and replacing anti-toxin growth promoters (AGPs) with direct-fed microbials. The continuous rise in the population has also resulted in an increase in the demand for food and the necessity for direct-fed microbials, to increase meat and milk production in a sustainable manner. A decline in the usage of anti-infection growth promoters across the globe is driving the sales of direct-fed microbials. Factors such as, high cost of direct-feed microbials and low shelf life are prompting an ascent in the cost of production and limiting the development of the market.
Asia-Pacific Direct Fed Microbials Market – By Type:
Lactic Acid Bacteria
Asia-Pacific Direct Fed Microbials Market – By Livestock:
Asia-Pacific Direct Fed Microbials Market – By Form:
On the basis of geography, the Asia-pacific market is analysed under various regions namely Japan, China, Australia, India and South Korea. Based on type, lactic acid bacteria is expected to be the quickest developing segment, as these direct fed microbials are highly viable. In terms of market share Lactic acid bacteria dominates then trailed by bacillus segment. The utilization of direct-fed microbials in animal feed is relied upon to increase at a faster pace in Europe and the Asia-Pacific regions because of the rising demand
Major players in the market are Archer Daniels Midland Company, E.I. Dupont De Nemours and Company, Koninklijke DSM N.V., Novozymes, Chr. Hansen Holding A/S, Kemin Industries, Inc., Biomin Holding GmbH, Lallemand, Inc., Novus International, Inc., Bio-Vet.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org